| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings, Inc. (CRBP) has 11 insiders with recent SEC Form 4 filings, including 30 buys and 12 sells. CRBP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| ? | 2.34M | $25.85M | - | |
| CEO | 188.2K | $2.07M | - | |
| Other | 99.2K | $1.09M | - | |
| CFO | 84.2K | $928.8K | - | |
| COO | 54.3K | $599.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2024 | Cohen Yuval65 | Chief Executive Officer | Sale+OE | 63,358 | $46.57 | $2,950,518.18 | -8.7% | +23.0% | -81.0% | |
| Jun 18, 2024 | Moran Sean F.61 | Chief Financial Officer | Sale+OE | 18,043 | $47.88 | $863,837.60 | -8.5% | +23.0% | -81.0% | |
| Mar 8, 2024 | Cormorant Asset Management, LP50 | - | Buy | 550,000 | $42.41 | $23,327,559.60 | +3.2% | +3.7% | -84.9% | |
| Feb 2, 2024 | Cormorant Asset Management, LP50 | - | Buy | 750,000 | $19.00 | $14,250,000.00 | +103.4% | +43.0% | -63.4% | |
| Jan 26, 2024 | Cormorant Asset Management, LP50 | - | Buy | 282,632 | $32.24 | $9,111,940.74 | +3.5% | +13.6% | -64.3% | |
| Aug 10, 2022 | Cohen Yuval65 | Chief Executive Officer | Buy | 3,800 | $0.26 | $1,003.20 | +4.0% | -49.8% | -16.6% | |
| Aug 10, 2022 | Moran Sean F.61 | Chief Financial Officer | Buy | 20,000 | $0.26 | $5,198.00 | +11.2% | -49.8% | -16.6% | |
| Aug 10, 2022 | Millian Craig Stuart | Chief Operating Officer | Buy | 5,000 | $0.25 | $1,272.50 | +22.7% | -49.8% | -16.6% | |
| May 16, 2022 | Moran Sean F.61 | Chief Financial Officer | Buy | 12,000 | $0.30 | $3,600.00 | +7.2% | -13.7% | +16.8% | |
| May 16, 2022 | Cohen Yuval65 | Chief Executive Officer | Buy | 10,500 | $0.25 | $2,625.00 | +12.5% | -13.7% | +16.8% |